NTAP vs SPRY · P/E 28, rev $6.57B vs rev $89.1M
NetApp Inc (NTAP) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported NTAP revenue for 2025-04-25 was $6.57B. Net income was $1.19B. Revenue was up 4.9% from 2024-04-26 to 2025-04-25. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
NTAP currently screens at market cap $35.43B and trailing P/E 28.2. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the NTAP and SPRY stock pages for the full models.
Not investment advice.